ABSTRACT After thirty-two years since the first domestic outbreak of human immunodeficiency virus(HIV)/acquired immune deficiency syndrome(AIDS)among injection drug users(IDUs)and almost two decades of comprehensive r...ABSTRACT After thirty-two years since the first domestic outbreak of human immunodeficiency virus(HIV)/acquired immune deficiency syndrome(AIDS)among injection drug users(IDUs)and almost two decades of comprehensive response efforts by the Chinese government,HIV/AIDS remains a major public health problem.The increasing burden of HIV/AIDS and comorbidities,the emergence of new HIV subtypes and/or circulating recombinant forms and drug mutations,the changing transmission networks.展开更多
Objective To review HIV/AIDS epidemic history, current situation and prevention policy in China. Data sources Information included in this article was identified by searching PUBMED （1997-2006） online resources usin...Objective To review HIV/AIDS epidemic history, current situation and prevention policy in China. Data sources Information included in this article was identified by searching PUBMED （1997-2006） online resources using the key terms ＂HIV/AIDS＂, ＂epidemic＂, ＂prevention＂, and ＂China＂. Study selection Original milestone articles and critical reviews written by major pioneer investigators of the field were selected. Results The key issues related to the HIV/AIDS epidemic situation in China and Chinese government prevention policy were summarized. HIV/AIDS epidemic groups and trends for HIV transmission were discussed. Conclusion In January 2006, 650 000 people were estimated to be living with HIV in China. The overall HIV/AIDS epidemic is at a low level （0.05%） and concentrated in several at risk populations. However, the data show that new cases of HIV infection are growing every year and spreading from at risk populations to the general population. Premier WEN Jia-bao announced the ＂Four frees and one care＂ policy and the Chinese government has developed a series of programs with strong policy measures to stop the spread of HIV/AIDS in China.展开更多
China’s Free ART Program was initiated in 2002 as an emergency response to save and improve the lives of AIDS patients living mainly in impoverished rural regions of central China. With little experience in HIV/AIDS ...China’s Free ART Program was initiated in 2002 as an emergency response to save and improve the lives of AIDS patients living mainly in impoverished rural regions of central China. With little experience in HIV/AIDS treatment and care and resource limitations, China’s efforts to provide widespread access to free antiretroviral therapy has been a process fraught with difficulty. However, the Free ART Program is progressing from an emergency response to a standardized treatment and care system. The development of national guidelines, training programs, a laboratory sup- port network, a national patient database, programs for special populations such as children and patients living with co- infections, and operational research has improved the scope and quality of the free treatment program. As of June 30, 2005, a total of 19,456 patients in 28 provinces, autonomous regions, and special municipalities had received free ART. Challenges stemming from the nature of China’s health system and patient population persist, but with strong govern- ment support and a diverse set of resources, China has the capacity to overcome these challenges and to provide nationwide access to high quality treatment and care.展开更多
Chinese medicine （CM） has been used in the treatment of human immunodeficiency virus （HIV） infection and acquired immunodeficiency syndrome （AIDS） for 30 years and the demonstrated therapeutic effects of CM, suc...Chinese medicine （CM） has been used in the treatment of human immunodeficiency virus （HIV） infection and acquired immunodeficiency syndrome （AIDS） for 30 years and the demonstrated therapeutic effects of CM, such as reducing plasma HIV viral load, increasing CD4＊T cell counts, promoting immunity reconstitution, ameliorating symptoms and signs, improving the health related quality of life （HRQOL） and counteracting against the effects of anti-retroviral drugs, were summarized and reviewed in this article. The authors point out that it had been a good opportunity to use CM for the treatment of HIV infection and AIDS in the past and also there are huge challenges ahead for CM research and clinicians to discover more effective CM and its underlying mechanisms for treatment of AIDS.展开更多
目的探讨槲皮素(Que)对免疫低下小鼠免疫功能的影响。方法 C57BL/6小鼠分为正常对照组、环磷酰胺(CTX)组、槲皮素(Que)组,每组10只。正常对照组、CTX组小鼠灌胃NS(每日0.2ml/只),Que组灌胃 Que 80mg/kg(每日0.2ml/只),连续灌胃20天,第1...目的探讨槲皮素(Que)对免疫低下小鼠免疫功能的影响。方法 C57BL/6小鼠分为正常对照组、环磷酰胺(CTX)组、槲皮素(Que)组,每组10只。正常对照组、CTX组小鼠灌胃NS(每日0.2ml/只),Que组灌胃 Que 80mg/kg(每日0.2ml/只),连续灌胃20天,第16天除正常对照组外其余两组小鼠连续3天腹腔注射CTX,每日50mg/kg。计数小鼠外周血白细胞,计算小鼠免疫器官指数,MTT法检测T、B淋巴细胞增殖,中性红吞噬实验检测巨噬细胞吞噬,流式细胞术检测脾细胞CD4比例和CD4/CD8比值及细胞凋亡率。结果与CTX组相比,Que组的外周血白细胞计数、脾指数、T淋巴细胞增殖率均升高(P<0.05),CD4比例及CD4/CD8 比值升高(P<0.05);淋巴细胞凋亡比率降低(P<0.05)。与正常对照组相比,Que组的脾指数、T和B淋巴细胞增殖能力、巨噬细胞吞噬功能、CD4比例及CD4/CD8比值差异无统计学意义,淋巴细胞凋亡比率升高(P<0.05)。结论槲皮素可以显著增强环磷酰胺造成的免疫低下小鼠的免疫功能。展开更多
In the past 37 years,human immunodeficiency virus/acquired immunodeficiency syndrome(HIV/AIDS)has undergone various major transmission routes in China,with the world most complex co-circulating HIV-1 subtypes,even the...In the past 37 years,human immunodeficiency virus/acquired immunodeficiency syndrome(HIV/AIDS)has undergone various major transmission routes in China,with the world most complex co-circulating HIV-1 subtypes,even the prevalence is still low.In response to the first epidemic outbreak of HIV in injecting drug users and the second one by illegal commercial blood collection,China issued the Anti-Drug Law and launched the Blood Donation Act and nationwide nucleic acid testing,which has avoided 98,232 to 211,200 estimated infections and almost ended the blood product-related infection.China has been providing free antiretroviral therapy(ART)since 2003,which covered>80%of the identified patients and achieved a viral suppression rate of 91%.To bend the curve of increasing the disease burden of HIV and finally end the epidemic,China should consider constraining HIV spread through sexual transmission,narrowing the gaps in identifying HIV cases,and the long-term effectiveness and safety of ART in the future.展开更多
基金Supported by Shanghai Municipal Health Commission(GWV-10.1-XK16)the National Natural Science Foundation of China(82173579,81773485)Yiwu Research Institute of Fudan University.
文摘ABSTRACT After thirty-two years since the first domestic outbreak of human immunodeficiency virus(HIV)/acquired immune deficiency syndrome(AIDS)among injection drug users(IDUs)and almost two decades of comprehensive response efforts by the Chinese government,HIV/AIDS remains a major public health problem.The increasing burden of HIV/AIDS and comorbidities,the emergence of new HIV subtypes and/or circulating recombinant forms and drug mutations,the changing transmission networks.
文摘Objective To review HIV/AIDS epidemic history, current situation and prevention policy in China. Data sources Information included in this article was identified by searching PUBMED （1997-2006） online resources using the key terms ＂HIV/AIDS＂, ＂epidemic＂, ＂prevention＂, and ＂China＂. Study selection Original milestone articles and critical reviews written by major pioneer investigators of the field were selected. Results The key issues related to the HIV/AIDS epidemic situation in China and Chinese government prevention policy were summarized. HIV/AIDS epidemic groups and trends for HIV transmission were discussed. Conclusion In January 2006, 650 000 people were estimated to be living with HIV in China. The overall HIV/AIDS epidemic is at a low level （0.05%） and concentrated in several at risk populations. However, the data show that new cases of HIV infection are growing every year and spreading from at risk populations to the general population. Premier WEN Jia-bao announced the ＂Four frees and one care＂ policy and the Chinese government has developed a series of programs with strong policy measures to stop the spread of HIV/AIDS in China.
文摘China’s Free ART Program was initiated in 2002 as an emergency response to save and improve the lives of AIDS patients living mainly in impoverished rural regions of central China. With little experience in HIV/AIDS treatment and care and resource limitations, China’s efforts to provide widespread access to free antiretroviral therapy has been a process fraught with difficulty. However, the Free ART Program is progressing from an emergency response to a standardized treatment and care system. The development of national guidelines, training programs, a laboratory sup- port network, a national patient database, programs for special populations such as children and patients living with co- infections, and operational research has improved the scope and quality of the free treatment program. As of June 30, 2005, a total of 19,456 patients in 28 provinces, autonomous regions, and special municipalities had received free ART. Challenges stemming from the nature of China’s health system and patient population persist, but with strong govern- ment support and a diverse set of resources, China has the capacity to overcome these challenges and to provide nationwide access to high quality treatment and care.
基金The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag Berlin Heidelberg 2013 ~Supported by the National Special S＆T Program on Major Infectious Diseases （No. 2013ZX10005001-001 and No. 2012ZX10005010-001-002）, the Research Project for Practice Development of National Traditional Chinese Medicine Clinical Research Bases （No. JDZX2012023）, and the Innovation Scientists and Technicians Troop Construction Projects of Zhengzhou City （No.10CXTD140）
文摘Chinese medicine （CM） has been used in the treatment of human immunodeficiency virus （HIV） infection and acquired immunodeficiency syndrome （AIDS） for 30 years and the demonstrated therapeutic effects of CM, such as reducing plasma HIV viral load, increasing CD4＊T cell counts, promoting immunity reconstitution, ameliorating symptoms and signs, improving the health related quality of life （HRQOL） and counteracting against the effects of anti-retroviral drugs, were summarized and reviewed in this article. The authors point out that it had been a good opportunity to use CM for the treatment of HIV infection and AIDS in the past and also there are huge challenges ahead for CM research and clinicians to discover more effective CM and its underlying mechanisms for treatment of AIDS.
文摘目的探讨槲皮素(Que)对免疫低下小鼠免疫功能的影响。方法 C57BL/6小鼠分为正常对照组、环磷酰胺(CTX)组、槲皮素(Que)组,每组10只。正常对照组、CTX组小鼠灌胃NS(每日0.2ml/只),Que组灌胃 Que 80mg/kg(每日0.2ml/只),连续灌胃20天,第16天除正常对照组外其余两组小鼠连续3天腹腔注射CTX,每日50mg/kg。计数小鼠外周血白细胞,计算小鼠免疫器官指数,MTT法检测T、B淋巴细胞增殖,中性红吞噬实验检测巨噬细胞吞噬,流式细胞术检测脾细胞CD4比例和CD4/CD8比值及细胞凋亡率。结果与CTX组相比,Que组的外周血白细胞计数、脾指数、T淋巴细胞增殖率均升高(P<0.05),CD4比例及CD4/CD8 比值升高(P<0.05);淋巴细胞凋亡比率降低(P<0.05)。与正常对照组相比,Que组的脾指数、T和B淋巴细胞增殖能力、巨噬细胞吞噬功能、CD4比例及CD4/CD8比值差异无统计学意义,淋巴细胞凋亡比率升高(P<0.05)。结论槲皮素可以显著增强环磷酰胺造成的免疫低下小鼠的免疫功能。
基金the Mega-Projects of national science research(13rd Five-Year Plan[No.2017ZX10201101])the Innovation Team Develop-ment Program of the Ministry of Education 2016(No.IRT_16R70).
文摘In the past 37 years,human immunodeficiency virus/acquired immunodeficiency syndrome(HIV/AIDS)has undergone various major transmission routes in China,with the world most complex co-circulating HIV-1 subtypes,even the prevalence is still low.In response to the first epidemic outbreak of HIV in injecting drug users and the second one by illegal commercial blood collection,China issued the Anti-Drug Law and launched the Blood Donation Act and nationwide nucleic acid testing,which has avoided 98,232 to 211,200 estimated infections and almost ended the blood product-related infection.China has been providing free antiretroviral therapy(ART)since 2003,which covered>80%of the identified patients and achieved a viral suppression rate of 91%.To bend the curve of increasing the disease burden of HIV and finally end the epidemic,China should consider constraining HIV spread through sexual transmission,narrowing the gaps in identifying HIV cases,and the long-term effectiveness and safety of ART in the future.
